JANX FY 2020 Earnings — Janux Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

JANXJanux Therapeutics, Inc.

$852M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$13,000

Operating Income

-$5M

Net Income

-$7M

EPS (Diluted)

$-0.16

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$72,000

Balance Sheet

Total Assets

$16M

Total Liabilities

$31M

Stockholders' Equity

-$15M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$13,000	-$6,000	-116.7%
Operating Income	-$5M	-$4M	-28.4%
Net Income	-$7M	-$4M	-60.1%